Correlation Between Newron Pharmaceuticals and Cicor Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Newron Pharmaceuticals and Cicor Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Newron Pharmaceuticals and Cicor Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Newron Pharmaceuticals SpA and Cicor Technologies, you can compare the effects of market volatilities on Newron Pharmaceuticals and Cicor Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Newron Pharmaceuticals with a short position of Cicor Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Newron Pharmaceuticals and Cicor Technologies.

Diversification Opportunities for Newron Pharmaceuticals and Cicor Technologies

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Newron and Cicor is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Newron Pharmaceuticals SpA and Cicor Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cicor Technologies and Newron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Newron Pharmaceuticals SpA are associated (or correlated) with Cicor Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cicor Technologies has no effect on the direction of Newron Pharmaceuticals i.e., Newron Pharmaceuticals and Cicor Technologies go up and down completely randomly.

Pair Corralation between Newron Pharmaceuticals and Cicor Technologies

Assuming the 90 days trading horizon Newron Pharmaceuticals SpA is expected to generate 4.07 times more return on investment than Cicor Technologies. However, Newron Pharmaceuticals is 4.07 times more volatile than Cicor Technologies. It trades about 0.05 of its potential returns per unit of risk. Cicor Technologies is currently generating about 0.07 per unit of risk. If you would invest  429.00  in Newron Pharmaceuticals SpA on August 31, 2024 and sell it today you would earn a total of  331.00  from holding Newron Pharmaceuticals SpA or generate 77.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Newron Pharmaceuticals SpA  vs.  Cicor Technologies

 Performance 
       Timeline  
Newron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Newron Pharmaceuticals SpA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Cicor Technologies 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cicor Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cicor Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Newron Pharmaceuticals and Cicor Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Newron Pharmaceuticals and Cicor Technologies

The main advantage of trading using opposite Newron Pharmaceuticals and Cicor Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Newron Pharmaceuticals position performs unexpectedly, Cicor Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cicor Technologies will offset losses from the drop in Cicor Technologies' long position.
The idea behind Newron Pharmaceuticals SpA and Cicor Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets